
Pharmacotherapy for Patients With Borderline Personality Disorder-Reply
John G. Gunderson, MD
Psychosocial Research Program McLean Hospital 115 Mill St Belmont, MA 02178
Arch Gen Psychiatry. 1988;45(2):196.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
A careful reading of the letter from Drs Goldberg and Schulz leaves me feeling that they did not feel altogether "flattered" or "gratified" by my commentary in the July 1986 issue of the ARCHIVES
It seems ironic that I should be fearful about the overzealous application of their finding, while their concern is that its value will go inadequately recognized—ironic because my fears reflect the substantial impact I expect their work to have, while their concern seems to reflect more humble expectations.
Fortunately, the new scientism that has permeated psychiatry and has an increasing impact on clinical practices provides an appeal court by which history will document whether my caution about overutilization or the investigators' fear of underutilization is warranted. Drs Goldberg and Schulz have pioneered research in this difficult area that will set a mark against which future treatment research can measure itself and by which their contribution itself
. . . [Full Text PDF of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|